Managing the risks of corruption arising from third parties is one of the most difficult challenges facing global organizations. The U.S. Foreign Corrupt Practices Act Clearinghouse shows that third-party intermediaries have been involved in 89% of enforcement actions.
Topics discussed include how a major pharmaceutical company built a world-class vendor compliance program, how to improve decision-making by leveraging analytics and AI technologies, and innovation workflow designs.
Learn how a pharmaceutical company is managing third-party risks better.